Sunday, July 12, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 66 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 9265734

    Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors

    BIOMARIN PHARMACEUTICAL INC. · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted
  2. US 9260416

    Heterocyclic autotaxin inhibitors and uses thereof

    AMIRA PHARMACEUTICALS, INC. · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted
  3. US 9260414

    Inhibitors of hepatitic C virus

    Theravance Biopharma R&D IP, LLC · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted
  4. US 9259452

    Deacetylase inhibitor therapy

    THE UNITED STATES OF AMERICA, DEPARTMENT OF HEALTH AND HUMAN SERVICES · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted
  5. US 9248119

    Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors

    Takeda Pharmaceuticals U.S.A., Inc. · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted
  6. US 9249473

    Compositions and methods for the identification of inhibitors of retroviral infection

    TRANA DISCOVERY, INC. · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted
  7. US 9243068

    Combination of SEMA-4D inhibitors and immunomodulators to inhibit tumors and metastases

    VACCINEX, INC. · Granted Jan 26, 2016 · Expires Jan 21, 2036

    granted
  8. US 9245290

    Caspase inhibitors and uses thereof

    The Regents of the University of California · Granted Jan 26, 2016 · Expires Jan 21, 2036

    granted
  9. US 9242000

    Micro-RNAs and micro-RNA inhibitors to modulate blood vessel growth, patterning, tumor growth and malignant disease and method for making and using them

    The Regents of the University of California · Granted Jan 26, 2016 · Expires Jan 21, 2036

    granted
  10. US 9238653

    Antimalarial agents that are inhibitors of dihydroorotate dehydrogenase

    The Board of Regents of the University of Texas System · Granted Jan 19, 2016 · Expires Jan 14, 2036

    granted
  11. US 9238676

    Peptide and peptidomimetic inhibitors

    RA PHARMACEUTICALS, INC. · Granted Jan 19, 2016 · Expires Jan 14, 2036

    granted
  12. US 9234000

    Benzylamine derivatives as inhibitors of plasma kallikrein

    KalVista Pharmaceuticals Limited · Granted Jan 12, 2016 · Expires Jan 7, 2036

    granted
  13. US 9233095

    Small molecule RNase inhibitors and methods of use

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jan 12, 2016 · Expires Jan 7, 2036

    granted
  14. AU 2014283378

    2,3-dihydrobenzofuran-5-yl compounds as DYRK kinase inhibitors

    4SC DISCOVERY GMBH [DE] · Granted Jan 7, 2016 · Expires Jan 2, 2036

    granted
  15. US 9226921

    Fused heterocyclic compounds as phosphodiesterases (PDES) inhibitors

    Takeda Pharmaceutical Company Limited · Granted Jan 5, 2016 · Expires Dec 31, 2035

    granted
  16. US 9220748

    Macrocyclic proline derived HCV serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Dec 29, 2015 · Expires Dec 24, 2035

    granted
  17. US 9221838

    Inhibitors of AKT activity

    ALMAC DISCOVERY LIMITED · Granted Dec 29, 2015 · Expires Dec 24, 2035

    granted
  18. US 9221843

    Heteroaryl inhibitors of PDE4

    Tetra Discovery Partners · Granted Dec 29, 2015 · Expires Dec 24, 2035

    granted
  19. US 9221772

    Synthesis of syrbactin proteasome inhibitors

    The Regents of the University of California · Granted Dec 29, 2015 · Expires Dec 24, 2035

    granted
  20. US 9216983

    Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity

    The Board of Regents of the University of Texas System · Granted Dec 22, 2015 · Expires Dec 17, 2035

    granted
  21. US 9212149

    Substituted 2-amidoquinazol-4-ones as matrix metalloproteinase-13 inhibitors

    Takeda Pharmaceutical Company Limited · Granted Dec 15, 2015 · Expires Dec 10, 2035

    granted
  22. US 9212191

    6-(2,3-dihydro-1H-pyrido-[2,3-b][1,4]oxazin-7-yl)-N-(4-morpholinophenyl)imidazo[1,2-a] pyrazin-8-amine as a spleen tyrosine kinase inhibitor

    GILEAD CONNECTICUT, INC. · Granted Dec 15, 2015 · Expires Dec 10, 2035

    granted
  23. US 9212168

    Hepatitis C virus inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Dec 15, 2015 · Expires Dec 10, 2035

    granted
  24. US 9206161

    Bridged bicyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Dec 8, 2015 · Expires Dec 3, 2035

    granted